BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2102902)

  • 1. Experimental strategies to explore the molecular details of MHC-peptide complexes.
    Rothbard JB; Busch R; Hill CM
    Int Rev Immunol; 1990; 6(1):1-21. PubMed ID: 2102902
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular components of T-cell recognition.
    Jorgensen JL; Reay PA; Ehrich EW; Davis MM
    Annu Rev Immunol; 1992; 10():835-73. PubMed ID: 1591005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes.
    Teng MK; Smolyar A; Tse AG; Liu JH; Liu J; Hussey RE; Nathenson SG; Chang HC; Reinherz EL; Wang JH
    Curr Biol; 1998 Mar; 8(7):409-12. PubMed ID: 9545202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three-dimensional structure of peptide-MHC complexes.
    Madden DR
    Annu Rev Immunol; 1995; 13():587-622. PubMed ID: 7612235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of T-cell alloreactivity.
    Felix NJ; Allen PM
    Nat Rev Immunol; 2007 Dec; 7(12):942-53. PubMed ID: 18007679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Types of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated data.
    Adrian PE; Rajaseger G; Mathura VS; Sakharkar MK; Kangueane P
    BMC Struct Biol; 2002 May; 2():2. PubMed ID: 12010576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].
    Boniface JJ; Rabinowitz JD; Wülfing C; Hampl J; Reich Z; Altman JD; Kantor RM; Beeson C; McConnell HM; Davis MM
    Immunity; 1998 Oct; 9(4):459-66. PubMed ID: 9806632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between immunogenic peptides and MHC proteins.
    Rothbard JB; Gefter ML
    Annu Rev Immunol; 1991; 9():527-65. PubMed ID: 1910688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens.
    Park MS; Park SY; Miller KR; Collins EJ; Lee HY
    Mol Immunol; 2013 Nov; 56(1-2):81-90. PubMed ID: 23688437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
    Stevanović S; Schild H
    Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the nature of physiologically processed antigen and on the conformation of peptides required for interaction with MHC.
    Grey HM; Demotz S; Buus S; Sette A
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():393-9. PubMed ID: 2639761
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of antigen presentation in vitro and in vivo by MHC antagonist peptides.
    Lamont AG; Sette A; Grey HM
    Int Rev Immunol; 1990; 6(1):49-59. PubMed ID: 1966393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of experimental autoimmune encephalomyelitis with ordered peptides based on MHC-TCR binding motifs.
    Ruiz PJ; DeVoss JJ; Nguyen LV; Fontoura PP; Hirschberg DL; Mitchell DJ; Garcia KC; Steinman L
    J Immunol; 2001 Sep; 167(5):2688-93. PubMed ID: 11509612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides.
    Burrack AL; Malhotra D; Dileepan T; Osum KC; Swanson LA; Fife BT; Jenkins MK
    J Immunol; 2018 Jan; 200(2):477-482. PubMed ID: 29255075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic peptide interaction with MHC molecules: implications for the design of artificial vaccines.
    Berzofsky JA
    Semin Immunol; 1991 Jul; 3(4):203-16. PubMed ID: 1932704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rules governing peptide-class II MHC molecule interactions.
    Hammer J; Nagy ZA; Sinigaglia F
    Behring Inst Mitt; 1994 Jul; (94):124-32. PubMed ID: 7998906
    [No Abstract]   [Full Text] [Related]  

  • 19. Rules for peptide binding to MHC class II molecules.
    Sinigaglia F; Hammer J
    APMIS; 1994 Apr; 102(4):241-8. PubMed ID: 7516671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHCPEP, a database of MHC-binding peptides: update 1997.
    Brusic V; Rudy G; Harrison LC
    Nucleic Acids Res; 1998 Jan; 26(1):368-71. PubMed ID: 9399876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.